Parp mutations protect from mitochondrial toxicity in Alzheimer’s disease
Abstract Alzheimer’s disease is the most common age-related neurodegenerative disorder. Familial forms of Alzheimer’s disease associated with the accumulation of a toxic form of amyloid-β (Aβ) peptides are linked to mitochondrial impairment. The coenzyme nicotinamide adenine dinucleotide (NAD+) is e...
Main Authors: | Yizhou Yu, Giorgio Fedele, Ivana Celardo, Samantha H. Y. Loh, L. Miguel Martins |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2021-06-01
|
Series: | Cell Death and Disease |
Online Access: | https://doi.org/10.1038/s41419-021-03926-y |
Similar Items
-
Correction: Parp mutations protect from mitochondrial toxicity in Alzheimer’s disease
by: Yizhou Yu, et al.
Published: (2021-07-01) -
Combined Transcriptomic and Proteomic Analysis of Perk Toxicity Pathways
by: Rebeka Popovic, et al.
Published: (2021-04-01) -
Mitochondrial Protection by PARP Inhibition
by: Ferenc Gallyas Jr, et al.
Published: (2020-04-01) -
Dynamic Interplay between Copper Toxicity and Mitochondrial Dysfunction in Alzheimer’s Disease
by: Giusy Tassone, et al.
Published: (2021-04-01) -
PARP INHIBITORS IN OVARIAN CANCER: TOXICITY PROFILE
by: S. V. KHOKHLOVA, et al.
Published: (2017-06-01)